Amyloid β Protein: Aβ40 Inhibits Aβ42 Oligomerization
Journal of the American Chemical Society2009Vol. 131(18), pp. 6316–6317
Citations Over TimeTop 10% of 2009 papers
Megan M. Murray, Summer L. Bernstein, Vy Nyugen, Margaret M. Condron, David B. Teplow, Michael T. Bowers
Abstract
Abeta40 and Abeta42 are peptides that adopt similar random-coil structures in solution. Abeta42, however, is significantly more neurotoxic than Abeta40 and forms amyloid fibrils much more rapidly than Abeta40. Here, mass spectrometry and ion mobility spectrometry are used to investigate a mixture of Abeta40 and Abeta42. The mass spectrum for the mixed solution shows the presence of a heterooligomer composed of equal parts of Abeta40 and Abeta42. Ion mobility results indicate that this mixed species comprises an oligomer distribution extending to tetramers. Abeta40 alone produces such a distribution, whereas Abeta42 alone produces oligomers as large as dodecamers. This indicates that Abeta40 inhibits Abeta42 oligomerization.
Related Papers
- → Oligomerization of Amyloid Aβ16–22 Peptides Using Hydrogen Bonds and Hydrophobicity Forces(2004)132 cited
- → Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid(2009)49 cited
- → Oligomer Formation of Amyloid-β(29–42) from Its Monomers Using the Hamiltonian Replica-Permutation Molecular Dynamics Simulation(2016)49 cited
- → Amyloid oligomer detection by immobilized molecular chaperone(2011)6 cited
- 基礎の部 ● 演題 2デスミン心筋症マウスに対するニコランジルの心筋保護効果(2011)